| Name | Title | Contact Details |
|---|
Lumen Bioscience develops oral antibody therapeutics.
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea.
NICO gives hope to patients with primary and secondary brain tumors, cysts and hemorrhagic strokes.